Huron Consulting Group Inc. (NASDAQ:HURN) is a global professional services firm that provides consulting services to a variety of industries, including healthcare, education, and financial services. The company helps organizations improve performance, manage change, and navigate complex challenges. Huron competes with other consulting firms like McKinsey & Company and Boston Consulting Group, but it has carved out a niche with its specialized services.
HURN has shown promising performance recently, with a gain of approximately 12.08% over the past 30 days. This indicates strong upward momentum for the stock. However, in the last 10 days, the stock has seen a slight decline of about 3.56%. This dip could present a buying opportunity for investors, as it may have reached a local minimum.
The stock's growth potential is estimated at 14.38%, suggesting there is still room for appreciation. This potential is supported by a robust Piotroski Score of 8. The Piotroski Score is a measure used to assess a company's financial health and operational efficiency. A score of 8 indicates that HURN is performing well across various financial metrics.
The target price for HURN is set at $165, aligning with its growth potential and current market conditions. Investors seeking a stock with solid fundamentals and growth prospects may find HURN to be an attractive option. However, it's crucial to conduct thorough research and consider market conditions before making any investment decisions.
Symbol | Price | %chg |
---|---|---|
6532.T | 6186 | -1.16 |
MEJA.JK | 444 | 0 |
4373.T | 2711 | 0.18 |
9757.T | 2205 | -0.82 |
Huron Consulting Group Inc. (NASDAQ:HURN) is a global professional services firm that provides consulting services to a variety of industries, including healthcare, education, and life sciences. The company helps organizations improve performance, reduce costs, and drive growth through strategic planning and operational improvements. Huron competes with other consulting firms like McKinsey & Company and Boston Consulting Group.
HURN has shown promising performance, with a notable gain of approximately 9.51% over the past month. This indicates strong upward momentum, suggesting that the stock is on a positive trajectory. However, in the last 10 days, the stock has seen a slight decline of about 2.15%. This dip could present a buying opportunity for investors looking to capitalize on its potential rebound.
The stock's growth potential is impressive, with an estimated upside of 16.91%. This suggests that HURN has room to grow and could reach the target price of $165. For investors seeking growth opportunities, this makes HURN an attractive option, as it indicates the potential for significant returns.
HURN's Piotroski Score is a robust 8, indicating strong financial health. The Piotroski Score is a measure of a company's financial strength, and a high score suggests that the company has strong fundamentals. This supports HURN's growth prospects and reassures investors of its financial stability.
Additionally, HURN has recently touched a local minimum, which could signal a potential reversal. This presents an opportunity for investors to enter at a favorable price point. Overall, Huron Consulting Group Inc. (NASDAQ:HURN) presents a compelling case for investors looking for a stock with strong growth potential and solid financial health.
Huron Consulting Group Inc. (NASDAQ:HURN) is a professional services firm based in Chicago, Illinois. Since its inception in 2002, Huron has provided consultancy services across various sectors, including healthcare, business advisory, and education. The company competes with other consulting firms in these sectors, offering strategic insights and solutions to its clients.
The stock target price for Huron has remained stable at $150 over the past month and quarter, reflecting consistent analyst sentiment. This stability suggests that analysts have maintained their outlook on the stock in the short term. However, analyst Tobey Sommer from Truist Financial has set a lower price target of $140, indicating a more conservative view.
Huron's recent financial performance has been strong, with the company reporting earnings of $1.68 per share for Q3 2024, surpassing the Zacks Consensus Estimate of $1.58. This performance marks an improvement from the $1.39 per share reported in the same quarter last year. The company also achieved a 3% revenue growth for the quarter ending September 30, 2024.
The company's consistent growth in its Healthcare and Education segments since the first quarter of 2021 has contributed to its positive financial results. Huron has increased its earnings guidance for 2024, suggesting confidence in its future performance. Investors should keep an eye on the upcoming earnings report and Investor Day for further insights.
Huron's upcoming financial results announcement for the fourth quarter and full year ending December 31, 2024, is scheduled for February 25, 2025. The conference call will be led by CEO Mark Hussey and CFO John Kelly. Investors are advised to monitor these events, as they could impact stock target prices and provide valuable information on the company's strategic direction.